Professor Joseph Doyle honoured with 2024 Frank Fenner Award
ASID’s new President Professor Joseph Doyle has been awarded the 2024 Frank Fenner Award for Advanced Research in Infectious Diseases.
Named after Professor Frank Fenner, an Australian pioneer of viral research, it is the peak research award from the Australasian Society for Infectious Diseases (ASID), awarded annually based on a portfolio of original research in infectious diseases.
Professor Joseph Doyle is a clinician-researcher and dual-trained infectious diseases and public health physician. He heads a program of clinical researchers, implementation scientists and epidemiologists that develop interventions and evidence to enhance hepatitis testing, care and treatment.
He completed his MPH at the London School of Hygiene and Tropical Medicine, his PhD at Monash School of Population Health, and hold specialist fellowships from Royal Australasian College of Physicians and Australasian Faculty of Public Health Medicine. He is currently Professor in Infectious Diseases at Monash University, and is jointly appointed at Burnet Institute as Deputy Director of Disease Elimination Program and Head of Infectious Diseases Clinical Research. He continues to work in clinical practice as a senior infectious diseases specialist at Alfred Health.
Accepting the Award at the ASID Annual Scientific Meeting in Wellington, New Zealand, Professor Doyle said he was grateful to receive such a prestigious accolade from ASID.
“It’s recognition of the work of my team over the past decade, and the fantastic mentoring I’ve received from many other ASID members, especially past Fenner awardees Profs Margaret Hellard, Greg Dore, Sharon Lewin and Anton Peleg," Professor Doyle said.
Outgoing ASID President Professor Katie Flanagan said that Professor Doyle’s research focuses on clinical implementation studies striving to find innovative testing and treatment models to achieve the WHO global goal of viral hepatitis elimination by 2030.
“His research has far reaching health and knowledge impacts for 52 million people globally, and 100,000 Australians, living with HCV because significant personal, system and social obstacles limit their engagement in care,” said Professor Flanagan.
The 2024 Frank Fenner Award was judged by Professor Josh Davis, Professor Fiona Russell and Professor Asha Bowen.
Media Contact: Alison Sweeney alison@asid.com.au or 0425 221 155.